Daniel Valtuena Maestre is a pharmaceutical entrepreneur with legal and financial background. He is the co-founder of Alphanosos and CEO of SYHA (www.syha-paris.com). Prior to Alphanosos key experience included CEO at Filaxis (Speciality Pharma developed internationally and sold to Fresenius), CFO at Manteia Predictive Medicine (a spin-off from Serono), VP Taxes(Finances) at Serono, and Senior Legal Consulting Manager at Price Waterhouse.